葡醛酸钠在肝力新注射液中的配伍稳定性考察  

Investigate the Compatible Stabilities of Sodium Glucuronic Acid Injection and Ganlixin Injection

作　　者：严俊[1] 茹仁萍[1] 

机构地区：[1]浙江省杭州市第六人民医院,310014

出　　处：《医学研究杂志》2006年第8期73-74,共2页Journal of Medical Research

摘　　要：目的考察葡醛酸钠在肝力新注射液中的配伍稳定性。方法以葡醛酸钠与肝力新注射液配伍,采用紫外分光光度法考察不同时间葡醛酸钠、肝力新的含量,并同时观察配伍液外观并测定pH、不溶性微粒。结果实验温度下(15°C)4h内配伍液的外观、pH、不溶性微粒及相对百分含量均无显著变化。结论葡醛酸钠与肝力新注射液配伍4h内是稳定的。Objective Investigate the compatible stabilities of Sodium Glucuronic Acid Injection and Ganlixin Injection. Methods The Sodium Glucuronic Acid Injection mixed with Ganlixin Injection, to study the content of Sodium Glucuronlc Acid Injection and Ganlixin Injection in different time by uv spectrophotometry , Investigate the appearance of the mixed solution, detect PH values and Insoluble Particles. Results At experimental temperature （15℃） , the mixed solution, PH values, Insoluble Particles and the relative percentage have no obvious change in 4 hours. Conclusions The Sodium Glucuronic Acid Injection mixed with Ganlixin Injection is stabilization, so Sodium Glucuronic Acid Injection can combined with Ganlixin Injection.

关 键 词：葡醛酸钠 肝力新 配伍 稳定性 

分 类 号：R978.11[医药卫生—药品] R975.5[医药卫生—药学]